UMIN ID: C000000119
Registered date:07/09/2005
Gene evaluation for antihypertensive drug effects study
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | essential hypertension |
Date of first enrollment | 2004/04/01 |
Target sample size | 300 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | thiazide diuretics indapamide calcium channel blocker amlodipine angiotensin II receptor blocker valsartan |
Outcome(s)
Primary Outcome | gene polymorphisms relating to blood pressure lowering effect of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker |
---|---|
Secondary Outcome | gene polymorphisms relating to side effects of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | severe hypertension (more than 180 and/or 110 mmHg) secondary hypertension female with pregnancy |
Related Information
Primary Sponsor | National Cardiovascular Center |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Research grant from the Japanese Ministry of Health, Labor, and Welfare |
Secondary ID(s) |
Contact
public contact | |
Name | Kei Kamide |
Address | 5-7-1, Fujishirodai, Suita, Osaka 565-8565 Japan |
Telephone | 06-6833-5012 |
kamide@hsp.ncvc.go.jp | |
Affiliation | National Cardiovascular Center Division of Hypertension and Nephrology |
scientific contact | |
Name | Yuhei Kawano |
Address | 5-7-1, Fujishirodai, Suita, Osaka 565-8565 Japan |
Telephone | 06-6833-5012 |
Affiliation | National Cardiovascular Center Division of Hypertension and Nephrology |